BSAC Spring Conference

Reigniting the AMR agenda

THIS CONFERENCE IS CPD ACCREDITED AND WILL BE AVAILABLE UNTIL 10 AUGUST 2022

HELD 10-11 MAY 2022. REGISTER NOW TO ACCESS THE RECORDED CONTENT

Welcome to the BSAC Spring Conference 2022

You can still register below to view the recorded content from this online conference.

If you have already registered, please use the login information you were sent on registration to access the recorded content.  For any queries, please contact Esme Carruthers.

This conference is RCPath CPD accredited and will be available until 10 August 2022.

 

Programme

Select to see different time zones. Default is BST.

0920
1020
1450
1120
0420
Welcome and opening remarks
Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio

SESSION ONE: THE IMPORTANCE OF DATA AND COMMUNICATION
Chair: Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
0930
1030
1500
1130
0430
The vital role of data in pandemic preparedness and management
Dr Susan Hopkins, Consultant, PHE/ DHSC / Royal Free Hospital - View Bio
0950
1050
1520
1150
0450
Data-driven communication to raise awareness of AMR and drive rational use of antibiotics
Dr Alex Costa, Health Programme Team, UNICEF - View Bio
1010
1110
1540
1210
0510
Q&A

1025
1125
1555
1225
0525
BREAK, EXHIBITION & POSTER VIEWING

SESSION TWO: ROUTINE OR RAPID - HOW DO WE GET IT RIGHT?
Chair: Dr Nick Brown, Consultant Medical Microbiologist, Cambridge University Hospitals NHS Trust - View Bio
1110
1210
1640
1310
0610
Was the Longitude Prize too early? Are we ready for rapid diagnostics?
Mr Daniel Berman, Director, Global Health, Nesta Challenges - View Bio
1130
1230
1700
1330
0630
The blood culture pathway - how can we get it right?
Dr Michael Weinbren, AMR Diagnostics Programme Clinical Lead, NHS England and NHS Improvement
1150
1250
1720
1350
0650
The effectiveness of rapid diagnostic tests for antimicrobial resistance
Dr Rebecca Glover, Assistant Professor in Health Policy, LSHTM - View Bio
1210
1310
1740
1410
0710
Q&A - all speakers, plus panellist Dr Rosemary Stevenson, AMR Diagnostics Programme Lead (Science & Policy Lead), NHS England and NHS Improvement

SESSION THREE: SPOTLIGHT TALK
Supported by: Baxter
1230
1330
1800
1430
0730
Every Patient who could have OPAT, should have OPAT – the importance of data
Katie Holgate, York and Scarborough Hospitals - View Bio
Hannah Bolton, York and Scarborough Hospitals - View Bio

SESSION FOUR: SPOTLIGHT SESSION
Supported by: Menarini
1250
1350
1820
1450
0750
The role of oral antimicrobial therapies and long-acting lipoglycopeptides in supporting early discharge for complex SSTIs
Dr Matthew Dryden, Royal Hampshire Hospital, Winchester & University of Southampton, United Kingdom Rare and Imported Pathogens Dept, UKHSA, Porton - View Bio

1320
1420
1850
1520
0820
LUNCH, EXHIBITION & POSTER VIEWING

1320
1420
1850
1520
0820
BSAC AGM - For BSAC Members

SESSION FIVE: ROUND TABLE DISCUSSION
Supported by: Shionogi
1430
1530
2000
1630
0930
Cefiderocol use in a complex transplant patient

SESSION SIX: VACCINES - WHAT NOW? WHAT NEXT?
Chair: Professor Philip Howard OBE, AMR Regional Antimicrobial Stewardship Lead, NHS England & NHS Improvement - North-East & Yorkshire, UK and immediate Past President, BSAC - View Bio
1515
1615
2045
1715
1015
Lessons learnt from COVID vaccine development 
Dr Charlie Weller, Head of Prevention, Infectious Diseases, Wellcome - View Bio
1535
1635
2105
1735
1035
Pneumococcal vaccine – a success story in progress
Professor Keith Klugman, Director, Bill & Melinda Gates Foundation - View Bio
1555
1655
2125
1755
1055
Q&A

SESSION SEVEN: Keynote Lecture
Chair: Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
1620
1720
2150
1820
1120
The GRAM report - implications for infection management
Dr Christopher J.L. Murray, Chair of Health Metrics Sciences, University of Washington & Director of the Institute for Health Metrics and Evaluation (IHME). - View Bio
1640
1740
2210
1840
1140
Q&A

SESSION EIGHT: The physician, the pharmacist, the nurse and their microbiologist - the pivotal role of a MDT approach to behavioural science
Chair: Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - - View Bio
1700
1800
2230
1900
1200
Interactive panel presentations and discussion on the successes and failures of behavioural science interventions
Dr Esmita Charani, Senior Lead Pharmacist, Imperial College London - View Bio
Professor Carolyn Tarrant, Professor of Health Services Research, University of Leicester - View Bio
Dr Eva Krockow, Lecturer in Psychology, University of Leicester - View Bio
Ms Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital - View Bio
1730
1830
2300
1930
1230
Panel discussion

1800
1900
2330
2000
1300
Day one closing remarks
Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
1900
2000
0030
2100
1400
Conference dinner
SESSION NINE: CLINICAL LESSONS
Chair: Ms Sally Tipping, Specialist Antimicrobial Pharmacist, Royal Devon & Exeter Hospital - View Bio
0800
0900
1330
1000
0300
Nuances of implementing antibiotic stewardship in high prescribing English general practices: an implementation study
Dr Sarah Tonkin-Crine, Associate Professor and Health Psychologist, University of Oxford - View Bio
0815
0915
1345
1015
0315
TRAIL, IP-10, CRP Host-protein Signature score distinguishes between Viral and Bacterial Infection in Sepsis Patients
Dr Jeroen Stas, Medical Affairs Manager, MeMed Diagnostics - View Bio
0830
0930
1400
1030
0330
ST97 Staphylococcus aureus and oxacillin resistance: An emerging challenge for microbiologists?
Gareth Hughes, ST7 Microbiology & Infectious diseases, UKHSA Lab - View Bio
0845
0945
1415
1045
0345
Q&A

SESSION TEN: INFECTION CONUNDRUMS
Chair: Dr Sanjay Patel, Consultant in Paediatric Infectious Diseases and Immunology, Southampton Children’s Hospital - View Bio
0900
1000
1430
1100
0400
Approaches to Complex Urinary Tract Infections
Dr Annie Joseph, Consultant Microbiologist, Nottingham University Hospitals NHS Trust - View Bio
Dr Tom Lewis, Northern Devon NHS Healthcare Trust - View Bio
0920
1020
1450
1120
0420
Intra-abdominal infections
Professor Mark Wilcox, Consultant / Head of Microbiology Research & Development / and Infection Lead of the Leeds NIHR Diagnostic Technologies Medical Technology and In Vitro Diagnostic Co-operative, Leeds Teaching Hospitals NHS Trust - View Bio
0940
1040
1510
1140
0440
Management of penicillin allergy labels
Dr Jonathan Sandoe, Associate Professor, University of Leeds, Leeds Teaching Hospitals NHS Trust - View Bio
1000
1100
1530
1200
0500
Recent trends in serious fungal infection incidence, mortality and antifungal resistance
Professor David Denning, Professor of Infectious Diseases in Global Health, The University of Manchester - View Bio
1020
1120
1550
1220
0520
Q&A

1035
1135
1605
1235
0535
REFRESHMENT BREAK, POSTER VIEWING

SESSION ELEVEN: SPOTLIGHT TALK
Supported by: Pfizer
1100
1200
1630
1300
0600
Antimicrobial Stewardship: Leadership and Accountability
Mrs Frances Garraghan, Specialist antimicrobial pharmacist, Manchester University NHS Foundation Trust - View Bio

SESSION TWELVE: EQUITABLE ACCESS
Chair: Mr Daniel Berman, Director, Global Health, Nesta Challenges - View Bio
1125
1225
1655
1325
0625
Accelerating appropriate access to new antibiotics: Cefiderocol as a pathfinder
Jennifer Cohn, Global Access Project Leader, Global Antibiotic Research and Development Partnership (GARDP) - View Bio
1145
1245
1715
1345
0645
Laboratory capacity for all - developing mobile laboratory services
Dr Alessandra Natale, Research Coordinator, Médecins Sans Frontières - View Bio
1205
1305
1735
1405
0705
Q&A

SESSION THIRTEEN: SPOTLIGHT SESSION
Supported by: Tillotts
1225
1325
1755
1425
0725
Impact of the pandemic on Clostridioides difficile & new guidance for treatment
Mr Paul Wade, Consultant Pharmacist – Infectious Diseases, Guy’s & St. Thomas’ NHS Foundation Trust

1255
1355
1825
1455
0755
LUNCH, NETWORKING & POSTER VIEWING

SESSION FOURTEEN: ACCREDITATION AND COLLABORATION - THE BEST WAY FORWARD!
Chair: Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
1340
1440
1910
1540
0840
Supporting shared learning and stakeholder collaboration via the Global Antimicrobial Stewardship hub (GASP-h)
Professor Dilip Nathwani - View Bio
1350
1450
1920
1550
0850
Developing a UK Antimicrobial Registry – a BSAC collaboration with academic and industry partners
Dr Jacqueline Sneddon, Programmes Manager, BSAC - View Bio
1400
1500
1930
1600
0900
Launch of the Global Antimicrobial Stewardship Accreditation Scheme (GAMSAS) – supporting a quality improvement approach
Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio
1410
1510
1940
1610
0910
Civil-private sector-public alliance: AMR, COVID-19, and the Investment Community
Professor Dilip Nathwani - View Bio
Dr Claudie Charbonneau, Pfizer - View Bio
1420
1520
1950
1620
0920
Panel discussion & Q&A

SESSION FIFTEEN: ANTIMICROBIAL SUSCEPTIBILITY TESTING
Chair: Dr Mandy Wootton, Consultant Scientist / Operational Manager, Specialist Antimicrobial Chemotherapy Unit, Public Health Wales, University Hospital of Wales - View Bio
1455
1555
2025
1655
0955
Interpreting EUCAST recommendations
Pegah Hafezi, AST LEAD, Severn Pathology, Bristol - View Bio
1515
1615
2045
1715
1015
Implementing RAST in routine microbiology services
Dr Per Rydstrom, Consultant clinical microbiologist, Clinical microbiology for Kronoberg and Blekinge County, Sweden - View Bio
1535
1635
2105
1735
1035
Whole genome sequencing as a tool for prediction of antimicrobial resistance: pros & cons
Dr Massimo Mentasti, Senior Scientist, Public Health Wales NHS Trust - View Bio
1555
1655
2125
1755
1055
Q&A

1615
1715
2145
1815
1115
Closing remarks
Dr David Jenkins, Consultant Medical Microbiologist, Infection Prevention doctor & BSAC President, University Hospitals of Leicester NHS Trust - View Bio

REGISTRATION

For any questions regarding registration, please contact Esme Carruthers.

£80

BSAC Members (NHS/not for profit)

Full conference

£40

BSAC Members (NHS/not for profit)

One day

£130

Non-members (NHS/not for profit)

Full conference

£65

Non-members (NHS/not for profit)

One day

£50

Student & LMIC concessions

Full conference

£25

Student & LMIC concessions

One day

£400

Commercial

Full conference

£200

Commercial

One day

Abstracts

Abstract submission

Submission is now closed

Sponsorship

For details of sponsorship opportunities at this conference, please contact Esme Carruthers.

RCP offers highly versatile facilities

Including tiered auditoriums, conference, meeting, exhibition and dining spaces.
Top